Onglyza
Links shared publicly online about this topic
FDA Approves Onglyza (saxagliptin) for Type 2 Diabetes
drugs.com — “Onglyza (saxagliptin) is used to treat Type 2 diabetes. Includes Onglyza side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 1, 2009 at 3:03 am By:
FDA Approves Onglyza (saxagliptin) for Type 2 Diabetes - http://bit.ly/19lKrd
FDA approves kidney disease label for Onglyza - Bloomberg
bloomberg.com — “NEW YORK (AP) --" Bristol-Myers Squibb Co. and AstraZeneca PLC said Wednesday they are expanding the label of their diabetes drug Onglyza, adding information about the drug's effects in patients with kidney failure.” View full resource at bloomberg.com
Most Recently Shared on February 25, 2011 at 7:45 pm By:
Nephrology News Health News and Nephrology
FDA approves kidney disease label for diabetes drug Onglyza. http://ow.ly/43zhq
Bristol, Astra's Onglyza controls diabetes: trial | Reuters
feeds.reuters.com — “LOS ANGELES (Reuters) - An interim look at a long-term study of Onglyza, under development by Bristol-Myers Squibb Co and AstraZeneca Plc, continued to show lowered glucose levels when used in combination” View full resource at feeds.reuters.com
Most Recently Shared on June 6, 2009 at 3:45 pm By:
Bristol, Astra's Onglyza controls diabetes: trial http://r.reuters.com/zyj66c
Onglyza expands European licence | InPharm
inpharm.com — “InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.” View full resource at inpharm.com
Most Recently Shared on March 4, 2011 at 2:14 pm By:
Pharmafocus Health News and Pharma
Onglyza expands European licence http://goo.gl/fb/gTWfr
Onglyza approved for use in renal impairment | MIMS online
mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS online” View full resource at mims.co.uk
Most Recently Shared on March 30, 2011 at 8:46 am By:
First DPP4 inhibitor approved for use in moderate to severe renal impairment: http://www.mims.co.uk/news/1061181
Diabetes drug Onglyza receives another European OK - CBS News
cbsnews.com — “Diabetes drug Onglyza receives another European OK” View full resource at cbsnews.com
Most Recently Shared on November 28, 2011 at 5:30 pm By:
Diabetes drug Onglyza receives another European OK: Diabetes drug Onglyza receives another European OK http://t.co/9M0F0gYc
FDA approves new diabetes drug Onglyza - Diabetes- msnbc.com
msnbc.msn.com — “Federal health regulators on Friday approved a potential blockbuster diabetes drug from Bristol-Myers Squibb Co. and partner Astrazeneca PLC.” View full resource at msnbc.msn.com
Most Recently Shared on July 31, 2009 at 11:21 pm By:
msnbc.com - Health Health News
FDA approves new diabetes drug Onglyza http://bit.ly/tF9Ph
ONGLYZA™ (saxagliptin) Launched In The UK For The Treatment Of Type 2 Diabetes
medicalnewstoday.com — “Bristol-myers squibb company and astrazeneca announced the launch of onglyza™ (saxagliptin) in the uk for the treatment of type 2 diabetes in adults, as add-on therapy with metformin, a thia” View full resource at medicalnewstoday.com
Most Recently Shared on October 16, 2009 at 3:31 pm By:
ONGLYZA™ (saxagliptin) Launched In The UK For The Treatment Of Type 2 Diabetes: Bristol-Myers Squibb Comp.. http://bit.ly/4y6x0f
Saxagliptin (Onglyza) Approved for Diabetes Approved by FDA - Health Blog - WSJ
blogs.wsj.com — “The FDA approved a new diabetes drug in a class Merck has had to itself since 2006.” View full resource at blogs.wsj.com
Most Recently Shared on July 31, 2009 at 8:03 pm By:
Leigh Ann Otte Health Magazine
FDA approves new type-2 diabetes drug: http://snurl.com/of70n (@WSJHealthBlog)
Saxagliptin (Onglyza) Approved for Diabetes Approved by FDA - Health Blog - WSJ
blogs.wsj.com — “The FDA approved a new diabetes drug in a class Merck has had to itself since 2006.” View full resource at blogs.wsj.com
Most Recently Shared on July 31, 2009 at 7:45 pm By:
Saxagliptin Approval: Finally, Competition for Merck’s Januvia http://bit.ly/11UCBy
Onglyza Sanctioned for Type 2 Diabetes - Health News - Health.com
news.health.com — “Onglyza (saxagliptin) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes in adults, the agency said Friday.” View full resource at news.health.com
Most Recently Shared on August 3, 2009 at 4:41 pm By:
Onglyza Sanctioned for Type 2 Diabetes: Onglyza (saxagliptin) has been approved by the U.S. Food and Drug Admini.. http://bit.ly/FkZPK
Zachary Bloomgarden, MD: the Onglyza launch | CurrentMedicine.tv
currentmedicine.tv — “Diabetes expert Zachary Bloomgarden, MD of Mount Sinai medical Center in New York discusses the newly approved DPP4-inhibtor drug, Onglyza (saxagliptin) to” View full resource at currentmedicine.tv
Most Recently Shared on October 9, 2009 at 5:18 pm By:
Healthcare Channel Health Site
Video: the new diabetes drug Onglyza launches. How will it be used? http://tinyurl.com/pfjqew
European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes
news-medical.net — “Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved ONGLYZA (saxagliptin) for use as a combination therapy with insulin (with or without metformin) to improve blood sugar (glycaemic) control in adult patients with type 2 diabetes.” View full resource at news-medical.net
Most Recently Shared on November 28, 2011 at 3:53 pm By:
Diabetes News: European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes: Bri... http://t.co/IjDwRuPp
European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes
news-medical.net — “Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved ONGLYZA (saxagliptin) for use as a combination therapy with insulin (with or without metformin) to improve blood sugar (glycaemic) control in adult patients with type 2 diabetes.” View full resource at news-medical.net
Most Recently Shared on November 28, 2011 at 5:30 pm By:
European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes: Bristol-Myers Squi... http://t.co/mO9KYHaO
Onglyza delay but AstraZeneca's Iressa set for EU return -
pharmatimes.com — “Onglyza delay but AstraZeneca's Iressa set for EU return -” View full resource at pharmatimes.com
Most Recently Shared on April 25, 2009 at 6:46 pm By:
Onglyza delay but AstraZeneca’s Iressa set for EU return - http://tinyurl.com/dg9ghc
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Nephrology News
Your resource for the latest developments in renal care since 1987.
-
Reuters Health
Advertisement
